Menu

Filtros : "Coréia do Sul" "FCF" Removidos: "Landgraf, Mariza" "1964" "Financiamento CAPES" Limpar

Filtros

Refine with date range

  • 1

1 - 11 (11 records)

  • Artigo de periodico

    In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors (2024)

    Yousef, Malaz ; O’Croinin, Conor; Le, Tyson S; Park, Chulhun ; Zuo, Jieyu; Bou-Chacra, Nadia Araci ; Davies, Neal M ; Löbenberg, Raimar

    Source: Pharmaceutics. Unidade: FCF

    Subjects: FARMACOCINÉTICA, FARMACODINÂMICA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      YOUSEF, Malaz et al. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors. Pharmaceutics, v. 16, n. 6 p. 1-13 art. 768, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics16060768. Acesso em: 04 jul. 2024.

    • APA

      Yousef, M., O’Croinin, C., Le, T. S., Park, C., Zuo, J., Bou-Chacra, N. A., et al. (2024). In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors. Pharmaceutics, 16( 6 p. 1-13 art. 768). doi:10.3390/pharmaceutics16060768

    • NLM

      Yousef M, O’Croinin C, Le TS, Park C, Zuo J, Bou-Chacra NA, Davies NM, Löbenberg R. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors [Internet]. Pharmaceutics. 2024 ; 16( 6 p. 1-13 art. 768):[citado 2024 jul. 04 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16060768

    • Vancouver

      Yousef M, O’Croinin C, Le TS, Park C, Zuo J, Bou-Chacra NA, Davies NM, Löbenberg R. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors [Internet]. Pharmaceutics. 2024 ; 16( 6 p. 1-13 art. 768):[citado 2024 jul. 04 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16060768

  • Artigo de periodico

    Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions (2023)

    Yukuyama, Megumi Nishitani ; Zuo, Jieyu; Park, Chulhun; Yousef, Malaz ; Henostroza, Mirla Anali Bazan; Araujo, Gabriel Lima Barros de ; Bou-Chacra, Nadia Araci ; Löbenberg, Raimar

    Source: International Journal of Pharmaceutics. Unidade: FCF

    Subjects: FÁRMACOS, ANTI-HELMÍNTICOS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      YUKUYAMA, Megumi Nishitani et al. Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions. International Journal of Pharmaceutics, v. 632, p. 1-9 art. 122554, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2022.122554. Acesso em: 04 jul. 2024.

    • APA

      Yukuyama, M. N., Zuo, J., Park, C., Yousef, M., Henostroza, M. A. B., Araujo, G. L. B. de, et al. (2023). Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions. International Journal of Pharmaceutics, 632, 1-9 art. 122554. doi:10.1016/j.ijpharm.2022.122554

    • NLM

      Yukuyama MN, Zuo J, Park C, Yousef M, Henostroza MAB, Araujo GLB de, Bou-Chacra NA, Löbenberg R. Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions [Internet]. International Journal of Pharmaceutics. 2023 ; 632 1-9 art. 122554.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1016/j.ijpharm.2022.122554

    • Vancouver

      Yukuyama MN, Zuo J, Park C, Yousef M, Henostroza MAB, Araujo GLB de, Bou-Chacra NA, Löbenberg R. Biphasic dissolution combined with modified cylinder method—A new promising method for dissolution test in drug-loaded nanoemulsions [Internet]. International Journal of Pharmaceutics. 2023 ; 632 1-9 art. 122554.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1016/j.ijpharm.2022.122554

  • Artigo de periodico

    Sub-cellular sequestration of alkaline drugs in lysosomes: new insights for pharmaceutical development of lysosomal fluid (2023)

    Yousef, Malaz ; Le, Tyson S; Zuo, Jieyu; Park, Chulhun; Bou-Chacra, Nadia Araci ; Davies, Neal M; Löbenberg, Raimar

    Source: Research in Pharmaceutical Sciences. Unidade: FCF

    Subjects: LISOSSOMOS, MEDICAMENTO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      YOUSEF, Malaz et al. Sub-cellular sequestration of alkaline drugs in lysosomes: new insights for pharmaceutical development of lysosomal fluid. Research in Pharmaceutical Sciences, v. 18, n. 1, p. 1-15, 2023Tradução . . Disponível em: https://doi.org/10.4103/1735-5362.363591. Acesso em: 04 jul. 2024.

    • APA

      Yousef, M., Le, T. S., Zuo, J., Park, C., Bou-Chacra, N. A., Davies, N. M., & Löbenberg, R. (2023). Sub-cellular sequestration of alkaline drugs in lysosomes: new insights for pharmaceutical development of lysosomal fluid. Research in Pharmaceutical Sciences, 18( 1), 1-15. doi:10.4103/1735-5362.363591

    • NLM

      Yousef M, Le TS, Zuo J, Park C, Bou-Chacra NA, Davies NM, Löbenberg R. Sub-cellular sequestration of alkaline drugs in lysosomes: new insights for pharmaceutical development of lysosomal fluid [Internet]. Research in Pharmaceutical Sciences. 2023 ; 18( 1): 1-15.[citado 2024 jul. 04 ] Available from: https://doi.org/10.4103/1735-5362.363591

    • Vancouver

      Yousef M, Le TS, Zuo J, Park C, Bou-Chacra NA, Davies NM, Löbenberg R. Sub-cellular sequestration of alkaline drugs in lysosomes: new insights for pharmaceutical development of lysosomal fluid [Internet]. Research in Pharmaceutical Sciences. 2023 ; 18( 1): 1-15.[citado 2024 jul. 04 ] Available from: https://doi.org/10.4103/1735-5362.363591

  • Trabalho de evento-resumo

    Fermented Bulgarian vegetables, source of bacteriocinogenic and antioxidants producing lactic acid bacteria (2023)

    Rwubuzizi, R; Carneiro, Kayque Ordonho; Holzapfel, W H; Franco, Bernadette Dora Gombossy de Melo ; Vaz-Velho, Manuela; Todorov, Svetoslav Dimitrov

    Source: Abstracts of Lectures & Posters. Conference titles: Beneficial Microbes Conference - Pre- and Probiotics for Lifelong Human and Animal Health. Unidade: FCF

    Assunto: ANÁLISE DE ALIMENTOS

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      RWUBUZIZI, R et al. Fermented Bulgarian vegetables, source of bacteriocinogenic and antioxidants producing lactic acid bacteria. 2023, Anais.. Amsterdam: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, 2023. . Acesso em: 04 jul. 2024.

    • APA

      Rwubuzizi, R., Carneiro, K. O., Holzapfel, W. H., Franco, B. D. G. de M., Vaz-Velho, M., & Todorov, S. D. (2023). Fermented Bulgarian vegetables, source of bacteriocinogenic and antioxidants producing lactic acid bacteria. In Abstracts of Lectures & Posters. Amsterdam: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.

    • NLM

      Rwubuzizi R, Carneiro KO, Holzapfel WH, Franco BDG de M, Vaz-Velho M, Todorov SD. Fermented Bulgarian vegetables, source of bacteriocinogenic and antioxidants producing lactic acid bacteria. Abstracts of Lectures & Posters. 2023 ;[citado 2024 jul. 04 ]

    • Vancouver

      Rwubuzizi R, Carneiro KO, Holzapfel WH, Franco BDG de M, Vaz-Velho M, Todorov SD. Fermented Bulgarian vegetables, source of bacteriocinogenic and antioxidants producing lactic acid bacteria. Abstracts of Lectures & Posters. 2023 ;[citado 2024 jul. 04 ]

  • Artigo de periodico

    Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons (2023)

    Yousef, Malaz ; Park, Chulhun ; Henostroza, Mirla ; Bou-Chacra, Nadia Araci ; Davies, Neal M ; Löbenberg, Raimar

    Source: Pharmaceutics. Unidade: FCF

    Subjects: SISTEMA LINFÁTICO, MEDICAMENTO

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      YOUSEF, Malaz et al. Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons. Pharmaceutics, v. 2, p. 1-17 art. 2532, 2023Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics15112532. Acesso em: 04 jul. 2024.

    • APA

      Yousef, M., Park, C., Henostroza, M., Bou-Chacra, N. A., Davies, N. M., & Löbenberg, R. (2023). Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons. Pharmaceutics, 2, 1-17 art. 2532. doi:10.3390/pharmaceutics15112532

    • NLM

      Yousef M, Park C, Henostroza M, Bou-Chacra NA, Davies NM, Löbenberg R. Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons [Internet]. Pharmaceutics. 2023 ; 2 1-17 art. 2532.[citado 2024 jul. 04 ] Available from: https://dx.doi.org/10.3390/pharmaceutics15112532

    • Vancouver

      Yousef M, Park C, Henostroza M, Bou-Chacra NA, Davies NM, Löbenberg R. Development of a novel in vitro model to study lymphatic uptake of drugs via artificial chylomicrons [Internet]. Pharmaceutics. 2023 ; 2 1-17 art. 2532.[citado 2024 jul. 04 ] Available from: https://dx.doi.org/10.3390/pharmaceutics15112532

  • Trabalho de evento-resumo periodico

    Lactococcus lactis LLGCK18: une bactérie lactique qui réduit l’antigénicité et l’allergénicité du gluten (2021)

    Mecherfi, K. E. El; Lupi, R; Albuquerque, M. De; Todorov, S. Dimitrov; Onno, B; Franco, Bernadette Dora Gombossy de Melo ; Larré, C

    Source: Nutrition Clinique. Conference titles: Les Journées Francophones de Nutrition. Unidade: FCF

    Subjects: LACTOCOCCUS, GLÚTEN, HIPERSENSIBILIDADE ALIMENTAR

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      MECHERFI, K. E. El et al. Lactococcus lactis LLGCK18: une bactérie lactique qui réduit l’antigénicité et l’allergénicité du gluten. Nutrition Clinique. Moulineaux: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.nupar.2021.01.088. Acesso em: 04 jul. 2024. , 2021

    • APA

      Mecherfi, K. E. E., Lupi, R., Albuquerque, M. D., Todorov, S. D., Onno, B., Franco, B. D. G. de M., & Larré, C. (2021). Lactococcus lactis LLGCK18: une bactérie lactique qui réduit l’antigénicité et l’allergénicité du gluten. Nutrition Clinique. Moulineaux: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.1016/j.nupar.2021.01.088

    • NLM

      Mecherfi KEE, Lupi R, Albuquerque MD, Todorov SD, Onno B, Franco BDG de M, Larré C. Lactococcus lactis LLGCK18: une bactérie lactique qui réduit l’antigénicité et l’allergénicité du gluten [Internet]. Nutrition Clinique. 2021 ; 35( 1 p. 63 res. P129):[citado 2024 jul. 04 ] Available from: https://doi.org/10.1016/j.nupar.2021.01.088

    • Vancouver

      Mecherfi KEE, Lupi R, Albuquerque MD, Todorov SD, Onno B, Franco BDG de M, Larré C. Lactococcus lactis LLGCK18: une bactérie lactique qui réduit l’antigénicité et l’allergénicité du gluten [Internet]. Nutrition Clinique. 2021 ; 35( 1 p. 63 res. P129):[citado 2024 jul. 04 ] Available from: https://doi.org/10.1016/j.nupar.2021.01.088

  • Artigo de periodico

    Viremia controls Env-specific antibody secreting cell responses in simian immunodeficiency virus infected macaques pre and post antiretroviral therapy (2021)

    Silveira, Eduardo Lani Volpe da ; Hong, Jung Joo; Amancha, Praveen K; Rogers, Kenneth A; Ansari, Aftab A; Byrareddy, Siddappa N; Villinger, Francois

    Source: AIDS. Unidade: FCF

    Subjects: LINFONODOS, CARGA VIRAL, SANGUE, ANTIRRETROVIRAIS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SILVEIRA, Eduardo Lani Volpe da et al. Viremia controls Env-specific antibody secreting cell responses in simian immunodeficiency virus infected macaques pre and post antiretroviral therapy. AIDS, v. 35, n. 13, p. 2085–2094, 2021Tradução . . Disponível em: https://doi.org/10.1097/QAD.0000000000002998. Acesso em: 04 jul. 2024.

    • APA

      Silveira, E. L. V. da, Hong, J. J., Amancha, P. K., Rogers, K. A., Ansari, A. A., Byrareddy, S. N., & Villinger, F. (2021). Viremia controls Env-specific antibody secreting cell responses in simian immunodeficiency virus infected macaques pre and post antiretroviral therapy. AIDS, 35( 13), 2085–2094. doi:10.1097/QAD.0000000000002998

    • NLM

      Silveira ELV da, Hong JJ, Amancha PK, Rogers KA, Ansari AA, Byrareddy SN, Villinger F. Viremia controls Env-specific antibody secreting cell responses in simian immunodeficiency virus infected macaques pre and post antiretroviral therapy [Internet]. AIDS. 2021 ; 35( 13): 2085–2094.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1097/QAD.0000000000002998

    • Vancouver

      Silveira ELV da, Hong JJ, Amancha PK, Rogers KA, Ansari AA, Byrareddy SN, Villinger F. Viremia controls Env-specific antibody secreting cell responses in simian immunodeficiency virus infected macaques pre and post antiretroviral therapy [Internet]. AIDS. 2021 ; 35( 13): 2085–2094.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1097/QAD.0000000000002998

  • Artigo de periodico

    Kefir: complex beneficial universe, combining sophisticate nutritional matrix and well established and balanced microbial consortium (2020)

    Bogsan, Cristina Stewart Bittencourt ; Todorov, Svestolav Dimitrov

    Source: EC Nutrition. Unidade: FCF

    Subjects: NUTRIÇÃO, SAÚDE, ALIMENTOS FERMENTADOS

    Versão PublicadaAcesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      BOGSAN, Cristina Stewart Bittencourt e TODOROV, Svestolav Dimitrov. Kefir: complex beneficial universe, combining sophisticate nutritional matrix and well established and balanced microbial consortium. EC Nutrition, v. 15, n. 7, p. 53-56, 2020Tradução . . Disponível em: https://www.ecronicon.com/ecnu/pdf/ECNU-15-00846.pdf. Acesso em: 04 jul. 2024.

    • APA

      Bogsan, C. S. B., & Todorov, S. D. (2020). Kefir: complex beneficial universe, combining sophisticate nutritional matrix and well established and balanced microbial consortium. EC Nutrition, 15( 7), 53-56. Recuperado de https://www.ecronicon.com/ecnu/pdf/ECNU-15-00846.pdf

    • NLM

      Bogsan CSB, Todorov SD. Kefir: complex beneficial universe, combining sophisticate nutritional matrix and well established and balanced microbial consortium [Internet]. EC Nutrition. 2020 ; 15( 7): 53-56.[citado 2024 jul. 04 ] Available from: https://www.ecronicon.com/ecnu/pdf/ECNU-15-00846.pdf

    • Vancouver

      Bogsan CSB, Todorov SD. Kefir: complex beneficial universe, combining sophisticate nutritional matrix and well established and balanced microbial consortium [Internet]. EC Nutrition. 2020 ; 15( 7): 53-56.[citado 2024 jul. 04 ] Available from: https://www.ecronicon.com/ecnu/pdf/ECNU-15-00846.pdf

  • Artigo de periodico

    Exploring beneficial/virulence properties of two dairy-related Strains of Streptococcus infantarius subsp. infantarius (2020)

    Santos, Karina Maria Olbrich dos; Matos, Carliane Ribeiro de; Salles, Hévila Oliveira; Franco, Bernadette Dora Gombossy de Melo ; Arellano, Karina; Holzapfel, Wilhelm Heinrich; Todorov, Svetoslav Dimitrov

    Source: Probiotics and Antimicrobial Proteins. Unidade: FCF

    Subjects: STREPTOCOCCUS, PROBIÓTICOS, VIRULÊNCIA, RESISTÊNCIA MICROBIANA ÀS DROGAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SANTOS, Karina Maria Olbrich dos et al. Exploring beneficial/virulence properties of two dairy-related Strains of Streptococcus infantarius subsp. infantarius. Probiotics and Antimicrobial Proteins, v. 12 , p. 1524-1541, 2020Tradução . . Disponível em: https://doi.org/10.1007/s12602-020-09637-8. Acesso em: 04 jul. 2024.

    • APA

      Santos, K. M. O. dos, Matos, C. R. de, Salles, H. O., Franco, B. D. G. de M., Arellano, K., Holzapfel, W. H., & Todorov, S. D. (2020). Exploring beneficial/virulence properties of two dairy-related Strains of Streptococcus infantarius subsp. infantarius. Probiotics and Antimicrobial Proteins, 12 , 1524-1541. doi:10.1007/s12602-020-09637-8

    • NLM

      Santos KMO dos, Matos CR de, Salles HO, Franco BDG de M, Arellano K, Holzapfel WH, Todorov SD. Exploring beneficial/virulence properties of two dairy-related Strains of Streptococcus infantarius subsp. infantarius [Internet]. Probiotics and Antimicrobial Proteins. 2020 ; 12 1524-1541.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1007/s12602-020-09637-8

    • Vancouver

      Santos KMO dos, Matos CR de, Salles HO, Franco BDG de M, Arellano K, Holzapfel WH, Todorov SD. Exploring beneficial/virulence properties of two dairy-related Strains of Streptococcus infantarius subsp. infantarius [Internet]. Probiotics and Antimicrobial Proteins. 2020 ; 12 1524-1541.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1007/s12602-020-09637-8

  • Artigo de periodico

    Inositol hexakisphosphate kinase 1 is a metabolic sensor in pancreatic beta-cells (2018)

    Rajasekaran, Subu Surendran; Kim, Jaeyoon; Gaboardi, Gian Carlo; Gromada, Jesper; Shears, Stephen B; Santos, Karen Tiago dos; Nolasco, Eduardo Lima; Ferreira, Sabrina de Souza; Illies, Christopher; Köhler, Martin; Gu, Chunfang; Ryu, Sung Ho; Martins, Joilson de Oliveira ; Daré, Elisabetta; Barker, Christopher J; Berggren, Per Olof

    Source: Cellular Signalling. Unidade: FCF

    Subjects: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, INSULINA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      RAJASEKARAN, Subu Surendran et al. Inositol hexakisphosphate kinase 1 is a metabolic sensor in pancreatic beta-cells. Cellular Signalling, v. 46, p. 120-128, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.cellsig.2018.03.001. Acesso em: 04 jul. 2024.

    • APA

      Rajasekaran, S. S., Kim, J., Gaboardi, G. C., Gromada, J., Shears, S. B., Santos, K. T. dos, et al. (2018). Inositol hexakisphosphate kinase 1 is a metabolic sensor in pancreatic beta-cells. Cellular Signalling, 46, 120-128. doi:10.1016/j.cellsig.2018.03.001

    • NLM

      Rajasekaran SS, Kim J, Gaboardi GC, Gromada J, Shears SB, Santos KT dos, Nolasco EL, Ferreira S de S, Illies C, Köhler M, Gu C, Ryu SH, Martins J de O, Daré E, Barker CJ, Berggren PO. Inositol hexakisphosphate kinase 1 is a metabolic sensor in pancreatic beta-cells [Internet]. Cellular Signalling. 2018 ; 46 120-128.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1016/j.cellsig.2018.03.001

    • Vancouver

      Rajasekaran SS, Kim J, Gaboardi GC, Gromada J, Shears SB, Santos KT dos, Nolasco EL, Ferreira S de S, Illies C, Köhler M, Gu C, Ryu SH, Martins J de O, Daré E, Barker CJ, Berggren PO. Inositol hexakisphosphate kinase 1 is a metabolic sensor in pancreatic beta-cells [Internet]. Cellular Signalling. 2018 ; 46 120-128.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1016/j.cellsig.2018.03.001

  • Artigo de periodico

    Early initiation of antiretroviral treatment postSIV infection does not resolve lymphoid tissue activation (2017)

    Hong, Jung Joo; Silveira, Eduardo Lani Volpe da ; Amancha, Praveen K.; Byrareddy, Siddappa N; Gumber, Sanjeev; Chang, Kyu-Tae; Ansari, Aftab A; Villinger, Francois

    Source: AIDS. Unidade: FCF

    Subjects: ANTIRRETROVIRAIS, IMUNOLOGIA, TECIDO LINFOIDE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      HONG, Jung Joo et al. Early initiation of antiretroviral treatment postSIV infection does not resolve lymphoid tissue activation. AIDS, v. 13, n. 31, p. 1819-1824, 2017Tradução . . Disponível em: https://doi.org/10.1097/qad.0000000000001576. Acesso em: 04 jul. 2024.

    • APA

      Hong, J. J., Silveira, E. L. V. da, Amancha, P. K., Byrareddy, S. N., Gumber, S., Chang, K. -T., et al. (2017). Early initiation of antiretroviral treatment postSIV infection does not resolve lymphoid tissue activation. AIDS, 13( 31), 1819-1824. doi:10.1097/qad.0000000000001576

    • NLM

      Hong JJ, Silveira ELV da, Amancha PK, Byrareddy SN, Gumber S, Chang K-T, Ansari AA, Villinger F. Early initiation of antiretroviral treatment postSIV infection does not resolve lymphoid tissue activation [Internet]. AIDS. 2017 ; 13( 31): 1819-1824.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1097/qad.0000000000001576

    • Vancouver

      Hong JJ, Silveira ELV da, Amancha PK, Byrareddy SN, Gumber S, Chang K-T, Ansari AA, Villinger F. Early initiation of antiretroviral treatment postSIV infection does not resolve lymphoid tissue activation [Internet]. AIDS. 2017 ; 13( 31): 1819-1824.[citado 2024 jul. 04 ] Available from: https://doi.org/10.1097/qad.0000000000001576
  • 1

1 - 11 (11 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024